Orchestra BioMed Receives $6.1 Million Milestone Payment from Acquisition of Vivasure by Haemonetics
Go back to Orchestra BioMed Receives $6.1 Million Milestone Payment from Acquisition of Vivasure by Haemonetics| HAEMONETICS CORPORATION (NYSE: HAE) | Delayed: 118.51 +2.35 (2.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $116.16 | 52 Week High | $39.41 | |||
| Open | $115.50 | 52 Week Low | $25.98 | |||
| Day High | $119.20 | P/E | 166.92 | |||
| Day Low | $115.49 | EPS | $0.71 | |||
| Volume | 777,372 | |||||
| (NASDAQ: OBIO) | Delayed: 5.59 +0.12 (2.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.47 | 52 Week High | $ | |||
| Open | $5.46 | 52 Week Low | $ | |||
| Day High | $5.66 | P/E | N/A | |||
| Day Low | $5.39 | EPS | $ | |||
| Volume | 262,009 | |||||



